DailyBubble News
DailyBubble News

Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to


Shares of Regeneron Pharmaceuticals Inc.
REGN,
-1.85%

slipped 1.85% to $735.36 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index
SPX,
+0.59%

rising 0.59% to 4,027.26 and the Dow Jones Industrial Average
DJIA,
+0.28%

rising 0.28% to 34,194.06. The stock’s fall snapped a two-day winning streak. Regeneron Pharmaceuticals Inc. closed $34.27 short of its 52-week high ($769.63), which the company reached on November 9th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson
JNJ,
+0.11%

rose 0.11% to $177.01, Novartis AG ADR
NVS,
-0.47%

fell 0.47% to $87.29, and Amgen Inc.
AMGN,
-1.27%

fell 1.27% to $283.40. Trading volume (406,207) remained 330,697 below its 50-day average volume of 736,904.


Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.



Read More: Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to

Comments are closed.